We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNC icon
376
PNC Financial Services
PNC
$99.1B
$3.79M 0.04%
36,039
-8,270
-19% -$871K
RHI icon
377
Robert Half
RHI
$4.11B
$3.78M 0.04%
71,551
-57,124
-44% -$2.71M
USB icon
378
US Bancorp
USB
$97.9B
$3.78M 0.04%
102,599
-25,235
-20% -$899K
A icon
379
Agilent Technologies
A
$39.6B
$3.75M 0.04%
42,472
-36,149
-46% -$2.96M
TWTR
380
CALL
DELISTED
Twitter, Inc.
TWTR
$3.74M 0.04%
+12,541,400
New +$378M
ARCT icon
381
Arcturus Therapeutics
ARCT
$165M
$3.73M 0.04%
+79,720
New +$2.75M
ATO icon
382
Atmos Energy
ATO
$29.7B
$3.7M 0.04%
37,128
-9,376
-20% -$946K
VEEV icon
383
Veeva Systems
VEEV
$33.8B
$3.61M 0.04%
15,416
-23,857
-61% -$4.73M
EOG icon
384
EOG Resources
EOG
$77.7B
$3.56M 0.04%
70,257
-6,078
-8% -$295K
RIGL icon
385
Rigel Pharmaceuticals
RIGL
$723M
$3.56M 0.04%
194,300
-50,000
-20% -$900K
KGC icon
386
Kinross Gold
KGC
$27.7B
$3.54M 0.04%
492,143
-497,475
-50% -$3.23M
RF icon
387
Regions Financial
RF
$26.4B
$3.52M 0.04%
316,594
-247,117
-44% -$2.63M
TNDM icon
388
Tandem Diabetes Care
TNDM
$1.27B
$3.46M 0.04%
+35,000
New +$2.79M
AYX
389
DELISTED
Alteryx Inc
AYX
$3.42M 0.04%
+2,820
New +$365K
IMVT icon
390
Immunovant
IMVT
$7.93B
$3.41M 0.04%
+140,000
New +$3M
TRV icon
391
Travelers Companies
TRV
$81.1B
$3.35M 0.04%
29,412
-8,483
-22% -$894K
SGMO
392
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.31M 0.04%
370,000
-150,000
-29% -$1.39M
TFC icon
393
Truist Financial
TFC
$63.9B
$3.31M 0.03%
88,006
-46,082
-34% -$1.66M
DVA icon
394
DaVita
DVA
$15.5B
$3.3M 0.03%
41,698
+12,832
+44% +$1M
GPN icon
395
Global Payments
GPN
$24.1B
$3.3M 0.03%
19,446
-10,612
-35% -$1.77M
FISV
396
Fiserv Inc
FISV
$29.7B
$3.27M 0.03%
33,468
-8,417
-20% -$848K
MRVL icon
397
Marvell Technology
MRVL
$147B
$3.22M 0.03%
91,926
-34,166
-27% -$1M
ICE icon
398
Intercontinental Exchange
ICE
$87.2B
$3.2M 0.03%
34,971
-14,194
-29% -$1.3M
CCL icon
399
Carnival Corporation Ltd
CCL
$38.1B
$3.13M 0.03%
190,752
+131,155
+220% +$1.97M
KZR
400
DELISTED
Kezar Life Sciences
KZR
$3.11M 0.03%
+60,000
New +$3.03M
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.